These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Emerging economies and diabetes and cardiovascular disease. Pradeepa R; Prabhakaran D; Mohan V Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S59-67. PubMed ID: 22650226 [TBL] [Abstract][Full Text] [Related]
24. The scourge of HIV and AIDS in Africa. Goncalves F South Afr Polit Econ Mon; 1994 Jun; 7(9):5-8. PubMed ID: 12287761 [TBL] [Abstract][Full Text] [Related]
25. Population aging and implications for epidemic cardiovascular disease in Sub-Saharan Africa. Smith SM; Mensah GA Ethn Dis; 2003; 13(2 Suppl 2):S77-80. PubMed ID: 13677418 [TBL] [Abstract][Full Text] [Related]
27. Epidemiological and nutrition transition in developing countries: impact on human health and development. Amuna P; Zotor FB Proc Nutr Soc; 2008 Feb; 67(1):82-90. PubMed ID: 18234135 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective. Yuyun MF; Sliwa K; Kengne AP; Mocumbi AO; Bukhman G Glob Heart; 2020 Feb; 15(1):15. PubMed ID: 32489788 [TBL] [Abstract][Full Text] [Related]
29. Measures of health and disease in Africa: are current methods giving us useful information about trends in cardiovascular diseases? Cooper RS; Bovet P Prog Cardiovasc Dis; 2013; 56(3):270-7. PubMed ID: 24267434 [TBL] [Abstract][Full Text] [Related]
30. Emigration dynamics in Sub-Saharan Africa. Adepoju A Int Migr; 1995; 33(3-4):315-90. PubMed ID: 12347006 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular disease in sub-Saharan Africa: a disaster waiting to happen. van der Sande MA Neth J Med; 2003 Feb; 61(2):32-6. PubMed ID: 12735418 [TBL] [Abstract][Full Text] [Related]
32. AIDS in Africa. ILO launches campaign on HIV / AIDS in the world of work. World Work; 1999; (31):22-3. PubMed ID: 12295604 [TBL] [Abstract][Full Text] [Related]
34. [Diabetes mellitus in sub-Saharan Africa: epidemiological aspects and management issues]. Gning SB; Thiam M; Fall F; Ba-Fall K; Mbaye PS; Fourcade L Med Trop (Mars); 2007 Dec; 67(6):607-11. PubMed ID: 18300524 [TBL] [Abstract][Full Text] [Related]
35. The global impact of noncommunicable diseases: estimates and projections. Manton KG World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413 [TBL] [Abstract][Full Text] [Related]
36. Measuring the economic and social consequences of CVDs and diabetes in India and Pakistan. Govender VM; Ghaffar A; Nishtar S Biosci Trends; 2007 Dec; 1(3):121-7. PubMed ID: 20103881 [TBL] [Abstract][Full Text] [Related]
37. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Gersh BJ; Sliwa K; Mayosi BM; Yusuf S Eur Heart J; 2010 Mar; 31(6):642-8. PubMed ID: 20176800 [TBL] [Abstract][Full Text] [Related]
38. Yellow fever in Africa: public health impact and prospects for control in the 21st century. Tomori O Biomedica; 2002 Jun; 22(2):178-210. PubMed ID: 12152484 [TBL] [Abstract][Full Text] [Related]
39. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues]. Kerouedan D Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595 [TBL] [Abstract][Full Text] [Related]